Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.62 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3395264 | 1.00 | TRIM24 (0.62) | TRIM24TRIM33ALDH1A1ESR2 | |
| SCHEMBL15467721 | 0.94 | TRIM24 (0.56) | TRIM24TRIM33ALDH1A1 | |
| SCHEMBL15467720 | 0.94 | TRIM24 (0.56) | TRIM24TRIM33ALDH1A1 | |
| SCHEMBL2196280 | 0.92 | TRIM24 (0.58) | TRIM24TRIM33ALDH1A1 | |
| SCHEMBL4584382 | 0.92 | TRIM24 (0.58) | TRIM24TRIM33ALDH1A1 | |
| SCHEMBL236422 | 0.92 | TRIM24 (0.58) | TRIM24TRIM33ALDH1A1 | |
| SCHEMBL2196275 | 0.92 | TRIM24 (0.58) | TRIM24TRIM33ALDH1A1 | |
| SCHEMBL4326621 | 0.92 | TRIM24 (0.58) | TRIM24TRIM33ALDH1A1 | |
| SCHEMBL4326613 | 0.92 | TRIM24 (0.58) | TRIM24TRIM33ALDH1A1 | |
| SCHEMBL4584380 | 0.92 | TRIM24 (0.58) | TRIM24TRIM33ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8212082-B2 | Process for the isolation of dodecatrienal and its use as aroma substance | BASF SE (DE) | 2012-07-03 | — | — | US | disclosed |
| US-8188320-B2 | Process for preparing pure cyclododecanone | BASF SE (DE) | 2012-05-29 | — | — | US | disclosed |
| US-20100190869-A1 | PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | CCNA1, CYC1, CCNA2 | TRIM24 3392/4885TRIM33 4369/4885ALDH1A1 503/4885 |
| US-20100190869-A1 | PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE | CCNA1, OXER1, CCNA2 | TRIM24 2928/4885TRIM33 4416/4885ALDH1A1 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.